Sessions are scheduled in local time (CEST)
Munich Hall
Industry Satellite Symposium
Date
Fri, 12.05.2023
Time
12:30 - 13:30
Room
Munich Hall
Chairs
- Wolfgang Janni (Ulm, Germany)
Gilead Sciences - BREAKING THROUGH: Overcoming challenges in the treatment of patients with triple-negative and HR+/HER2-metastatic breast cancer
Welcome and introduction - Treatment landscape and emerging needs in metastatic breast cancer: Where are we today? (ID 95)
Lecture Time
12:30 - 12:40
Room
Munich Hall
Date
Fri, 12.05.2023
Time
12:30 - 13:30
Speakers
- Wolfgang Janni (Ulm, Germany)
Authors
- Wolfgang Janni (Ulm, Germany)
Gilead Sciences - BREAKING THROUGH: Overcoming challenges in the treatment of patients with triple-negative and HR+/HER2-metastatic breast cancer
Optimal management in mTNBC: What have we learned from clinical practice? (ID 96)
Lecture Time
12:40 - 13:10
Room
Munich Hall
Date
Fri, 12.05.2023
Time
12:30 - 13:30
Speakers
- Ana Mafalda Antunes De Melo e Oliveira (Barcelona, Spain)
Authors
- Ana Mafalda Antunes De Melo e Oliveira (Barcelona, Spain)
Gilead Sciences - BREAKING THROUGH: Overcoming challenges in the treatment of patients with triple-negative and HR+/HER2-metastatic breast cancer
A new era of treatment for HR+/HER2- mBC: What do the clinical data tell us? (ID 97)
Lecture Time
13:10 - 13:30
Room
Munich Hall
Date
Fri, 12.05.2023
Time
12:30 - 13:30
Speakers
- Komal Jhaveri (New York, NY, United States of America)
Authors
- Komal Jhaveri (New York, NY, United States of America)
Gilead Sciences - BREAKING THROUGH: Overcoming challenges in the treatment of patients with triple-negative and HR+/HER2-metastatic breast cancer
Closing remarks (ID 98)
Lecture Time
13:30 - 13:30
Room
Munich Hall
Date
Fri, 12.05.2023
Time
12:30 - 13:30
Speakers
- Wolfgang Janni (Ulm, Germany)
Authors
- Wolfgang Janni (Ulm, Germany)